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Our understanding of the differential effects between specific 
omega-3 fatty acids is incomplete. Here, we aimed to evaluate 
the effects of docosahexaenoic acid (DHA) and eicosapentae-
noic acid (EPA) on T-helper type 1 (Th1) cell responses and 
identify the pathways associated with these responses. Naïve 
CD4+ T cells were co-cultured with bone marrow-derived den-
dritic cells (DCs) in the presence or absence of palmitate (PA), 
DHA, or EPA. DHA or EPA treatment lowered the number of 
differentiated IFN--positive cells and inhibited the secretion of 
IFN-, whereas only DHA increased IL-2 and reduced TNF- 
secretion. There was reduced expression of MHC II on DCs 
after DHA or EPA treatment. In the DC-independent model, 
DHA and EPA reduced Th1 cell differentiation and lowered 
the cell number. DHA and EPA markedly inhibited IFN- 
secretion, while only EPA reduced TNF- secretion. Micro-
array analysis identified pathways involved in inflammation, 
immunity, metabolism, and cell proliferation. Moreover, DHA 
and EPA inhibited Th1 cells through the regulation of diverse 
pathways and genes, including Igf1 and Cpt1a. Our results 
showed that DHA and EPA had largely comparable inhibitory 
effects on Th1 cell differentiation. However, each of the fatty 
acids also had distinct effects on specific cytokine secretion, 
particularly according to the presence of DCs. [BMB Reports 
2021; 54(5): 278-283]
INTRODUCTION
Omega-3 fatty acids, especially eicosapentaenoic acid (EPA), 
have shown remarkable cardiovascular benefits in a recent 
clinical trial (1). EPA was observed to reduce cardiovascular risk 
in all subgroups based on triglyceride levels, suggesting that 
the noted benefit can be independent of triglyceride reduction 
(2). However, we only partially understand the mechanisms of 
action of omega-3 fatty acids, particularly those involved in 
cardiovascular risk reduction.
Effects of omega-3 fatty acids on lipoprotein metabolism and 
plaque stabilization, and anti-inflammatory, anti-oxidation, and 
anti-thrombosis effects are considered to be possible routes of 
action (3, 4). It has been reported that docosahexaenoic acid 
(DHA) and EPA can affect the functions of macrophages and 
neutrophils (5). However, studies concerning the cardiovas-
cular effects of DHA or EPA and their mechanisms of action 
are highly limited, particularly in T cells.
A balance between functional phenotypes of T cells is known 
to contribute to atherosclerosis progression (6). Immune reaction 
in atherosclerosis is regarded as pathologic response of T helper 
cells with proinflammatory cytokine secretion (7). While a re-
lationship between T cells, such as CD4+ T cells, and coronary 
events has been reported (8), the effects of T cells on athero-
sclerosis can vary depending on their subtype, thus limiting 
clinical applications of T cell-associated targets. Although omega-3 
fatty acids are reportedly immunosuppressive in many cell 
types, including T cells, much remains unknown regarding 
their effects in these cells. Particularly, the knowledge of the 
differential effects between specific omega-3 fatty acids on 
T-cell response is not comprehensive (9). Therefore, the current 
study aims to evaluate the effects of DHA and EPA on Th1 cell 
responses including differentiation, proliferation, and cytokine 
secretion. Palmitate (PA) was used as a comparison. We mea-
sured the effects of DHA and EPA in the presence or absence 
of dendritic cells (DCs) to investigate whether the differences 
between fatty acids are influenced by DCs. Finally, we analyzed 
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Fig. 1. Effects of palmitate (PA), docosahexaenoic acid (DHA), and 
eicosapentaenoic acid (EPA) on differentiation, proliferation, and cyto-
kine secretion of T-helper type 1 (Th1) cells in a co-culture model. 
Naïve CD4+ T cells were co-cultured in the presence or absence 
of PA, DHA, or EPA (50 M). Intracellular IFN- production among 
differentiated CD4+ T cells was analyzed by FACS analysis. Repre-
sentative FACS plots (A) and relative quantification (B) indicate the 
effects of each fatty acid on differentiation of Th1 cells. Cell number 
was determined using a hemocytometer (C). In the same co-culture 
model with or without PA, DHA, or EPA, cytokine levels were deter-
mined by ELISA assay (D). Relative mRNA expression of Ifng, Tnf, 
Il2, and Tbx21 was measured by real-time PCR after cell differentia-
tion. Expression levels were normalized to mRNA levels of -actin 
(E). ELISA and qPCR were conducted with technical duplicates, and 
data were obtained from at least three independent experiments. 
*P ＜ 0.05; **P ＜ 0.01; ***P ＜ 0.001; ns: not significant compared with 
the control group; NC: negative control; C: control; PA: palmitic acid.
and validated the genes and pathways regulated by the two 
fatty acids in Th1 cells.
RESULTS
DHA and EPA, but not PA, inhibited DC-dependent Th1 cell 
differentiation, proliferation, and cytokines
The purity of CD4 positivity in isolated cells was ＞ 90% (Sup-
plementary Fig. 1). A DC-dependent Th1 cell differentiation 
model was used to assess the effects of each fatty acid. Naïve 
CD4+ T cells were co-cultured with BMDCs for 4 days in the 
presence or absence of PA, DHA, or EPA (50 M, respectively). 
The number of IFN-, a Th1 cell marker, -positive cells was 
significantly lower after DHA or EPA, but not PA treatment 
(Fig. 1A, B). Compared to the positive control group, the cell 
number was reduced upon DHA treatment. The cell number 
did not significantly change after PA or EPA treatment (Fig. 1C).
In the co-culture model, DHA and EPA markedly inhibited 
the secretion of IFN-, whereas only DHA significantly reduced 
that of TNF- (Fig. 1D). Similarly, DHA and EPA attenuated 
the expression of Ifng. No considerable alteration was observed 
in the expression of Tnf (Fig. 1E). PA did not influence the 
secretion of cytokines or the expression of the corresponding 
genes (Fig. 1D, E). Only DHA increased IL-2 secretion, while 
DHA and EPA upregulated the corresponding gene (Fig. 1D, 
E). EPA significantly decreased the expression of Tbet, a 
transcription factor for Ifng, whereas the effect of DHA on Tbet 
expression was not significant (Fig. 1E).
DHA and EPA reduced surface molecules on DCs
BMDCs were stimulated by lipopolysaccharide (LPS) (100 ng/ml) 
with or without PA, DHA, or EPA for 2 days. Representative 
histograms and mean fluorescence intensities (MFIs) are shown 
in Fig. 2. The levels of IL-12p40 and IL-12p70 in the media 
were measured using ELISA. DHA and EPA markedly decreased 
the expression of major histocompatibility complex (MHC) II, 
a co-stimulatory molecule expressed on DCs. Neither DHA 
nor EPA affected the expression of CD11c, CD80, or CD86. 
PA did not influence the expression of the three molecules 
(Fig. 2A). IL-12p70 level was reduced after treatment with 
DHA, whereas this change was not significant with EPA. The 
levels of IL-12p40 were not altered (Fig. 2B).
DHA and EPA inhibited DC-independent Th1 cell 
differentiation, proliferation, and cytokines
To determine bone marrow-derived dendritic cell (BMDC)-in-
dependent Th1 cell differentiation, cell culture plates were coated 
with anti-CD3 and anti-CD28. Naïve CD4+ T cells were then 
cultured in these plates for 4 days in the presence or absence 
of PA, DHA, or EPA (50 M). DHA, EPA, and PA reduced the 
differentiation of Th1 cells, while the effect of DHA and EPA 
was more remarkable (Fig. 3A, B). Additionally, DHA and EPA 
inhibited the proliferation of Th1 cells (Fig. 3C).
DHA, EPA, and PA decreased IFN- secretion, whereas the 
effect of DHA or EPA was more obvious (Fig. 3D). Conversely, 
only EPA dramatically reduced the secretion of TNF-. DHA 
and EPA remarkably inhibited Ifng expression, whereas the 
effects of DHA or EPA on Tnf were insignificant (Fig. 3E). The 
effects of the three fatty acids on IL-2 secretion and the 
expression of the corresponding gene were not significant (Fig. 
3D, E). The expression of Tbet was reduced by PA, DHA, and 
EPA (Fig. 3E).
Effects of PA on Th1 cell responses
The effect of PA was not significant on the differentiation, 
proliferation, and cytokine secretion of Th1 cells in the co-cul-
ture model. PA had a largely similar effect in a DC-indepen-
dent model, but reduced cell differentiation and IFN- secretion 
from Th1 cells.
DHA, EPA, and T cells
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Fig. 2. Effects of PA, DHA, and EPA on surface markers of BMDCs 
and IL-12p70 production. BMDCs were stimulated by LPS with or 
without PA, HAD, or EPA for 2 days. Representative FACS plots 
(A) and mean fluorescence intensity (MFI) (B) of CD11c, CD80, 
and MHCII expression are shown. MFI values for each group of 
cells were normalized to control (C). The levels of IL-12p40 and 
IL-12p70 in the culture media were measured by ELISA (D). Data 
were obtained from at least three independent experiments. *P ＜
0.05; **P ＜ 0.01; ***P ＜ 0.001; ns: not significant compared with 
the control group; NC: negative control; C: control; PA: palmitic acid.
Fig. 3. Effects of PA, DHA and EPA on BMDC-independent differ-
entiation, proliferation, and cytokine secretion of Th1 cells. BMDC- 
independent Th1 cell differentiation was analyzed using cell culture 
in plates pre-coated with anti-CD3 and anti-CD28. Naïve CD4+ T 
cells were then cultured in the plates in the presence or absence 
of PA, DHA, or EPA. Cell-surface expression of IFN- was analyzed 
by flow cytometry (A and B). The effects of DHA and EPA on 
Th1 cell proliferation and cell number were determined by CFSE assay 
and flow cytometry (C). The cytokine secretion and corresponding 
relative mRNA levels of IFN-, TNF-, and IL-2 were determined 
(D and E). mRNA levels of T-box transcription factor were measured 
by real-time PCR and are expressed as a ratio to GAPDH. The results 
of real-time PCR are expressed as a ratio to -actin. Both ELISA 
and qPCR were conducted in technical duplicates, and data were 
obtained from at least three independent experiments. *P ＜ 0.05; 
**P ＜ 0.001; and ***P ＜ 0.0001 compared with the control 
group. NC: negative control; C: control; ns: not significant.
Genes and pathways of Th1 cells regulated by DHA and EPA
To identify the genes of Th1 cells altered by DHA, naïve CD4+ 
T cells were cultured with BMDCs for 4 days with or without 
DHA (50 M). Using a microarray analysis, DEGs were compared 
after treatment with vehicle or DHA (Supplementary Fig. 1A). 
To determine the biologically relevant genes affected by DHA, 
we selected genes in the top ten pathways ranked by the 
analysis (Supplementary Table 1).
The associated pathways included but were not limited to, 
cytokine-cytokine receptor interaction, chemokine signaling, 
and fatty acid metabolism. Among the pathways, we focused 
on the Ras signaling pathway. Genes, including Tiam1, Efna5, 
and Igf1 were upregulated, whereas those including Prkacb, 
Gng2, Grin1, and Vegfa were downregulated by DHA (Supple-
mentary Table 1). Quantitative polymerase chain reaction (qPCR) 
for validation showed that expression levels of Igf1 significantly 
increased, whereas changes in other genes were not significant 
(Supplementary Fig. 1B).
To identify genes of Th1 cells affected by EPA, the same 
co-culture model, microarray analysis, and comparisons were 
used. The associated pathways included but were not limited 
to those involved in regulation of the hematopoietic cell lineage, 
cytokine-cytokine receptor interaction, and peroxisome prolife-
rator-activated receptor signaling. Genes including Cpt1a and 
Slc27a2 were upregulated, whereas several others, including 
Runx2, Vegfa, and Itga2, were downregulated by EPA (Supple-
mentary Table 1 and Supplementary Fig. 1D). The upregulation 
of Cpt1a and downregulation of Runx2 and Itga2 were vali-
dated (Supplementary Fig. 1E). 
Gene ontology (GO) categories for DEGs by DHA included 
immune system process and response, positive regulation of 
inflammation, and cytokine activity. Those of DEGs by EPA in-
cluded signal transduction, immune response, defense response 
to protozoa, positive regulation of T cells, and chemokine 
receptor activity (Supplementary Fig. 1C, F). Further experiments 
for validation of these role were conducted by inhibiting the 
Igf1 gene and Cpt-1a. Inhibition of Cpt-1a by etomoxir partly, 
but significantly, restored differentiation of Th1 cells decreased 
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by EPA. Although silencing of Igf1 by siRNA modestly in-
creased differentiation, the difference was not statistically 
significant (Supplementary Fig. 1G). 
DISCUSSION
The major findings of this study were as follows: DHA and 
EPA inhibited the differentiation of Th1 cells, regardless of the 
presence of DCs; DHA and EPA inhibited the DC-dependent 
differentiation of INF- positive cells and the secretion of IFN-, 
whereas only DHA increased IL-2 reduced TNF- secretion; 
DC-dependent effects of DHA and EPA were mediated, at least 
in part, by the downregulation of MHC II; the inhibitory effects 
on cytokines were more prominent for DHA in the presence of 
DCs and for EPA in the absence of DCs; PA did not have 
similar effects on Th1 cells. The working pathways of DHA 
and EPA in Th1 cells included but were not limited to those of 
inflammation, immunity, metabolism, and cell proliferation. 
The regulation of several genes, including Igf1 and Cpt1a, was 
also validated in this study. Notably, we demonstrated, for the 
first time, the distinct effects of DHA and EPA on specific 
cytokine secretion according to the presence of DCs, although 
these two fatty acids had largely similar inhibitory effects on 
Th1 cells.
A recent study showed that EPA and DHA have similar anti- 
inflammatory effects on CD4+ T cells as assessed using migration 
assays (10). The relatively neutral effect of PA on these T cells 
is in concordance with our findings. In our study, although 
EPA and DHA showed similar effects in Th1 cells, the effects 
of DHA tended to be more prominent in the presence of DCs, 
whereas some effects of EPA were more obvious in the 
DC-independent model. Currently, it is not fully understood 
how these two fatty acids exert distinct effects on cytokines. 
Possibly, their different inhibitory effects on DC, for example 
on surface molecules unexamined in our study (11), could be 
associated. Conversely, mammalian target of rapamycin (mTOR) 
on T cell is a crucial molecule for cellular metabolism and T 
cell differentiation and function (12). Furthermore, omega-3 
fatty acids are known to downregulate mTOR (13). Therefore, 
the effect of individual omega-3 fatty acids on T cell surface 
molecules, including mTOR, can differ, and this could account 
for the differences in cytokine secretion, as in our study.
In the current study, the inhibitory effects of EPA on DC- 
independent TNF- secretion were more obvious than those of 
the other fatty acids. TNF- is reportedly associated with a 
high incidence of cardiovascular events (14). Reduction of 
TNF- secretion in Th1 cells by EPA may be one of many 
biological mechanisms inducing clinical benefits. As shown in 
this study, DHA and EPA had differential effects on some 
responses of Th1 cells. Previously reported anti-inflammatory 
effects of DHA and EPA on diverse tissues and pathological 
environments related to TNF- (15, 16). Accordingly, our results 
demonstrating the distinct effects of DHA and EPA may provide 
insights into the mechanisms underlying their benefits in differ-
ent contexts rather than superiority of one over another.
A prior study revealed that DHA and EPA directly influenced 
and attenuated the secretion of IL-2 and the proliferation of T 
cells (17). Conversely, T cells of mice on a DHA- or EPA-enriched 
diet did not show a reduction in IL-2 transcription, while they 
suppressed IL-2R mRNA levels (18). We found that elevated 
IL-2 secretion was more dramatic following DHA treatment in 
the DC-dependent model. This might be one example of 
differential effects of omega-3 fatty acids according to the 
presence of DCs. In addition, it was of note that the increased 
IL-2 in the DC-dependent model was not accompanied by an 
enhanced T-cell proliferation. Recent studies identified the 
effects of IL-2 on regulatory T-cell expansion and protection 
from atherosclerosis (19). It would thus be of interest to 
evaluate whether IL-2 elevation in the current study is linked to 
the omega-3 fatty acid-driven cardiovascular benefit observed 
in recent clinical studies (1).
DHA or EPA treatment markedly reduced the expression of 
MHC II molecules. This could be one of the pivotal links 
between the two fatty acids and their DC-dependent effect. 
This finding was in line with other studies (20). In the current 
study, the effects of DHA and EPA on CD80 or CD86 were 
less clear than those on MHC II. DHA and EPA are precursors 
of specialized pro-resolving lipid mediators (9, 21) that can 
affect T-cell differentiation through regulating transcription 
factors (22). Among them, the resolvin D1 analog suppresses 
MHC II and CD40 expression, whereas it did not affect CD80 
and CD86 expression (23). Accordingly, pro-resolving mediators, 
such as resolvin D1, seem to modulate the interactions be-
tween DCs and T cells, preferably through the CD40/154 
pathway rather than the CD80/86-CD28 pathway. This is in 
concordance with our observation. However, we did not 
examine the effects of lipid mediators but only of omega-3 
fatty acids themselves. Thus, we cannot rule out the potential 
pathways in DCs, independent of mediators such as resolvins.
Studies performed in the past decades discovered that DHA 
and EPA change the basic properties of cell membranes, 
modulate lipid microdomains and immunological synapses, 
and regulate downstream cell signaling cascades and nuclear 
receptor activation (24). It was also suggested that the effects of 
DHA on T cells could be related to altered microdomains and 
downstream signaling (25, 26). In a model membrane, DHA 
influenced the membrane structure and fluidity, whereas EPA 
accumulated cholesterol-rich domains and inhibited inflamma-
tion (27). Although the association between the differential 
effects of the two fatty acids and changes in the membrane is 
beyond the scope of our study, it will be of interest to explore 
the issues in future studies.
The genes upregulated by DHA included Igf1. Observations 
of the effects of insulin-like growth factor signaling on athero-
sclerosis have been conflicting (28). The role of this gene has 
been evaluated in various cell types, including smooth muscle 
cells (29) and macrophages (30). Recombinant human insulin- 
like growth factor-1 (rhIGF-1) delivery has been shown to 
DHA, EPA, and T cells
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increase the number of T cells in mice (31). Although rhIGF-1 
stimulated the proliferation of regulatory T cells, it did not 
affect the proliferation of other proinflammatory T cell subsets 
(32). Conversely, a recent study reported that knockout of 
macrophage-derived IGF-1 gene in mice elevated Th1 (IFN-+) 
cell proportions (33). This indicates that IGF-1 or Igf1 may be 
involved in the inhibition of Th1 cell differentiation. Neverthe-
less, because research results vary, whether Igf1 plays a 
primary role in the proliferation and differentiation of Th1 cells 
needs to be further elucidated. Particularly, silencing of Igf1 
did not show dramatic impact on differentiation of Th1 cells 
post DHA treatment, and the mechanism of these effects remains 
to be additionally elucidated. 
The genes validated in our study include Cpt1a, a target 
gene of PPAR, which encodes carnitine palmitoyltransferase I 
(Cpt1). We demonstrated that upregulation of Cpt1a contributes, 
at least in part, to the inhibitory effect of EPA on Th1 cell 
differentiation. CPT1 contributes to mitochondrial fatty acid 
oxidation. It has been reported that EPA induces the expres-
sion of CPT1A in intestinal cells (34). In a mouse study, 
knocking out Cpt1a in endothelial cells promoted leukocyte 
infiltration, implying that Cpt1a may be atheroprotective (35). 
Furthermore, mitochondrial fatty acid oxidation, for which 
CPT1A has an important role, is reported to be essential for the 
survival and activation of CD8+ T cells (36). Interestingly, PD-1, 
a T cell surface protein, has been reported to promote fatty 
acid oxidation by increasing CPT1A expression. Because T 
cells utilize glycolysis during differentiation to effectors, this is 
responsible for PD-1-induced inhibition of T cell differentiation 
(37). In addition, this is in line with our finding that Cpt1a 
upregulation concomitantly suppressed T cell responses. Collec-
tively, it is possible that Cpt1a plays a role in multiple T-cell 
subtypes contributing to the vascular condition. 
Our study has potential limitations. We investigated the 
response of Th1 cells in DC-dependent or -independent manners. 
However, because there are other T-cell types involved in 
vascular immune response, our results may not provide a 
completely integrated perspective. Nevertheless, the primary 
purpose of our study was to evaluate the effects of DHA and 
EPA on Th1 cell responses. Additionally, we designed this 
study to perform only in vitro experiments. This nature of our 
current study has limitations when attempting to extrapolate 
the results to animal models or the clinical setting. However, 
we performed a comprehensive analysis to compare cellular 
responses induced by each of the target fatty acids.
DHA and EPA inhibited the activation of Th1 cells in both 
DC-dependent and -independent manners. Modest but signifi-
cant differential effects between DHA and EPA on Th1 cells 
were demonstrated for the first time. These two fatty acids 
regulated diverse genes, including Igf1 and Cpt1a in Th1 cells. 
Further studies of these differential effects on adaptive immunity 
are needed to clarify their beneficial effects on diverse sites 
and pathological conditions, including cardiovascular diseases.
MATERIALS AND METHODS
Detailed methods are described in Supplementary Material.
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